Overview

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a cisplatin-etoposide regimen improves survival in comparison to a regimen containing etoposide and without platinum derivative.
Phase:
Phase 3
Details
Lead Sponsor:
European Lung Cancer Working Party
Treatments:
Cisplatin
Epirubicin
Etoposide
Etoposide phosphate
Ifosfamide
Isophosphamide mustard